Elementis appoints Dr. Trudy Schoolenberg to its Board as Non-Executive Director and next Senior Independent Director

– UK, London –  Elementis plc (LON: ELM), a global specialty chemicals company, today announced the appointment of Dr. Trudy Schoolenberg to its Board as a Non-Executive Director with immediate effect.

Trudy will assume the role of Senior Independent Director after the AGM on 26 April 2022.

Trudy will also join the Audit, Nomination, and Remuneration Committees.

About Dr. Geertrui (Trudy) Schoolenberg

Trudy has over 30 years experience of working in the chemicals, engineering, and high-performance product sectors, including over 20 years with Royal Dutch Shell where she led business strategy and growth plans for Shell Chemicals. As well as strategy and growth experience, Dr. Schoolenberg has strong operational knowledge, gained both during her time at Shell and thereafter at Akzo Nobel from 2013-2017 where she was Global Director SRD of Akzo Nobel Decorative Paints.

Dr. Schoolenberg is a non-executive director of Accsys Technologies plc (AIM and Euronext listed), Supervisory board member of Avantium N.V.(Euronext Amsterdam SmallCap Index), and SPIE SA (Euronext Paris). Trudy previously served as a non-executive director and senior independent director at Spirax-Sarco Engineering plc (2012-2021), non-executive director and senior independent director of Low and Bonar plc (2013-2020), and non-executive director of not for profit, The Netherlands Petroleum Stockpiling Agency (2011-2021).

Dr. Schoolenberg has a Ph.D. in Technical Physics from the Delft University of Technology (Netherlands) and holds a master’s degree in Industrial Engineering.

For more information: https://www.elementis.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.